Food, diet, vitamins, trace elements, minerals, and additives have been part of folk treatments for mental disorders dating back to itinerant peddlers of snake oil. Foods are often touted by those outside the traditional medical mainstream as substitutes for established treatments. Parents often besiege the practitioner with unproved remedies because they may sound more benign and “natural” than drugs or behavior modification. Unproved dietary remedies are frequently promoted by alternative practitioners seeking a competitive advantage in the marketplace of mental health services. These practitioners often target psychopharmacology as “unnatural” and dangerous compared to the beneficent natural use of foods and diet, thus playing upon parental anxieties and allegiances to holistic medicine.
- Hyperactive Child
- Ventral Globus Pallidus
- Nootropic Drug
- Minimal Brain Dysfunction
- Brain Tryptophan
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
This is a preview of subscription content, access via your institution.
Unable to display preview. Download preview PDF.
Conners CK: Feeding the Brain: How Foods Affect Children. New York, Plenum, 1990.
Millichap JG: Nutrition, Diet, and Your Child’s Behavior. Springfield, Ill: CC Thomas, 1986.
Kanarek RB, Marks-Kaufman R: Nutrition and Behavior. New York, Van Nostrand Reinhold, 1991.
Conners CK: Food Additives and Hyperactive Children. New York, Plenum, 1980.
Conners CK: Sugars and hyperactivity, in Kretchmer N, Hollenbeck CB (eds): Sugars and Sweeteners. Boca Raton, Fla, CRC Press, 1991.
Gouliaev AH, Senning A: Piracetam and other structurally related nootropics. Brain Res Brain Res Rev 19: 180–222, 1994.
Wackermann J, Lehmann D, Dvorak I, Michel CM: Global dimensional complexity of multi-channel EEG indicates change of human brain functional state after a single dose of a nootropic drug. Electroencephalogr Clin Neurophysiol 86:193–198, 1993.
Giurgea C, Salama M: Nootropic drugs. Prog Neuropsychopharmacol 1:235–247, 1977.
Wurtman RJ, Magil SG, Reinstein DK: Piracetam diminishes hippocampal acetylcholine levels in rats. Life Sei 28:1091–1093, 1981.
Nyback H, Wiesel FA, Skett P: Effects of piracetam on brain monoamine metabolism and serum prolactin levels in the rat. Psychopharmacology 61:235–238, 1979.
Poschel BP, Marriott GG, Gluckman, MI: Pharmacology underlying the cognition-activating properties of Pramiracetam (CL-879). Psychopharmacol Bull 19:720–721, 1983.
Luthman J, Lindqvist E, Kojima H, Shiotani T, Tanaka M, Tachizawa H, Olson L: Effects of nefiracetam (DM-9384), a pyrrolidone derivative, on brain monoamine systems. Arch Int Pharmacodyn Ther 328:125–144, 1994.
Mondadori C: In search of the mechanism of action of the nootropics: New insights and potential clinical implications. Life Sei 55:2171–2178, 1994.
Mondadori C: The pharmacology of the nootropics; new insights and new questions. Behav Brain Res 59: 1–9, 1993.
Saletu B, Grunberger J, Anderer, R: On brain protection of co-dergocrine mesylate (Hydergine) against hypoxic hypoxidosis of different severity: Double-blind placebo-controlled quantitative EEG and psychometric studies. Int J Clin Pharmacol Ther Toxicol 28:510–524, 1990.
Turo va NF, Ermolina LA, Baryshnikov VA, Kopaladze RA, Aziavchik AV: [Effect of nootropic agents on serum biochemical indices in intellectually deficient children.] Zh Nevropatol Psikhiatrii Imeni S S Korsa-kova 83:1558–1563, 1983.
Dimond S, Brouwers EYM: Increase in the power of human memory in normal man through the use of drugs. Psychopharmacology (Berlin) 49:307–309, 1976.
Wilsher C: A brief review of studies of piracetam in dyslexia. J Psychopharmacol 1:95–100, 1987.
Conners CK, Blouin AG, Winglee M, et al: Piracetam and event-related potentials in dyslexic males. Int J Psychophysiology 4:19–27, 1986.
Conners CK, Reader M, Reiss A, et al: The effects of piracetam upon visual event-related potentials in dyslexic children. Psychophysiology 24:513–521, 1987.
Dilanni M, Wilsher CR, Blank MS, Conners CK, et al: The effects of piracetam in children with dyslexia. J Clin Psychopharmacol 5:272–278, 1985.
Somnier FE, Ostergaard MS, Boysen G, Brunn P, Mikkelsen BO: Aniracetam tested in chronic psychosyndrome after long-term exposure to organic solvents. A randomized, double-blind, placebo-controlled cross-over study with neuropsychological tests. Psychopharmacology (Berlin) (QGI) 101:43–46, 1990.
Aman MG, Rojahn J: Pharmacological intervention, in Singh NN, Beale IL (eds): Learning Disabilities: Nature, Theory, and Treatment. New York, Springer-Verlag, 1992, pp. 478–525.
Galler JR (ed): Nutrition and Behavior. New York, Plenum, 1984.
Wurtman RJ, Wurtman JJ (eds): Nutrition and the Brain, vols 1–4. New York, Raven Press, 1977–79.
Wolraich ML, Wilson DB, White, JW: The effect of sugar on behavior or cognition in children. A metaanalysis. JAMA 274:1617–1621, 1995.
National Academy of Sciences: Sweeteners: Issues and Uncertainties. Washington, DC: National Academy of Sciences, 1975.
Bennett FC, Sherman R: Management of childhood “hyperactivity” by primary care physicians. J Dev Behav Pediatr 4:88–93, 1983.
Prinz RJ, Roberts WA, Hantman E: Dietary correlates of hyperactive behavior in children. J Consult Clin Psychol 48:760–769, 1980.
Wolraich ML, Milich R, Stumbo P, Schultz F: Effects of sucrose ingestion on behavior of hyperactive boys. J Pediatr 106:675–682, 1985.
Prinz RJ, Riddle DB: Associations between nutrition and behavior in five-year-old children. Nutr Rev 44 (Suppl.):151–158, 1986.
Lester ML, Thatcher RW, Monroe-Lord L: Refined carbohydrate intake, hair cadmium levels, and cognitive functioning in children. Nutr Behav 1:3–13, 1982.
White JW, Wolraich M: Effect of sugar on behavior and mental performance. Am J Clin Nutr 62:242S-247S, 1995.
Hoover DW, Milich R: Effects of sugar ingestion expectancies on mother-child interactions. J. Abnorm Child Psychol 22:501–515, 1994.
Render J, Lifshitz F: The effects of fluctuations of blood glucose levels on the psychological performance of juvenile diabetics. Diabetes 25(Abstract):334, 1976.
Holmes CS, Hayford JT, Gonzalez JL, Weydert JA: A survey of cognitive functioning at different glucose levels in diabetic persons. Diabetes Care 6:180–185, 1983.
Lapp JE: Effects of glycémie alterations and noun imagery on the learning of paired associates. J Learn Disabil 14:35–38, 1981.
Behar D, Rapoport JL, Adams AJ, et al:Sugar challenge testing with children considered behaviorally “sugar reactive.” Nutr Behav 1:277–288, 1984.
Milich R, Pelham WE: The effects of sugar ingestion on the classroom and playgroup behavior of attention deficit disordered boys. J Consult Clin Psychol 54:714–718, 1986.
Goldman JA, Lerman RH, Contois JH, et al: Behavioral effects of sucrose on preschool children. J Abnorm Child Psychol 14:565–577, 1986.
Conners CK, Glasgow A, Raiten D, et al: Hyperactives differ from normals in blood sugar and hormonal response to sucrose. Paper presented at the Annual Meeting of the American Psychological Association, New York, 1987.
Fernstrom JD, Wurtman RJ: Brain serotonin content: Physiological dependence on plasma tryptophan levels. Science 173:149–152, 1971.
Fernstrom JD, Wurtman RJ: Brain serotonin content: Increase following ingestion of carbohydrate diet. Science 174:1023–1025, 1971.
Luft R, Cerasi E, Madison LL, et al: Effect of a small decrease in blood-glucose on plasma-growth hormone and urinary excretion of catecholamines in man. Lancet 2:254–256, 1966.
Stegink LD: The aspartame story: A model for the clinical testing of a food additive. Am J Clin Nutrit 46: 204–215, 1987.
Leon AS, Hunninghake DB, Bell C, et al: Safety of long-term large doses of aspartame. Arch Int Med 149:2318–2324, 1989.
Shaywitz BA, Anderson GM, Novotny EJ, Ebersole JS, Sullivan CM, Gillespie SM: Aspartame has no effect on seizures or epileptiform discharges in epileptic children. Ann Neurol 35:98–103, 1994.
Wolf-Novak LC, Stegink LD, Brummel MC, et al: Aspartame ingestion with and without carbohydrate in Phenylketonurie and normal subjects: Effect on plasma concentrations of amino acids, glucose, and insulin. Metabolism 39:391–396, 1990.
Mackey SA, Berlin CM Jr: Effect of dietary aspartame on plasma concentrations of phenylalanine and tyrosine in normal and homozygous Phenylketonurie patients. Clin Pediatr 31:394–399, 1992.
Trefz F, deSonneville L, Matthis P, Benninger C, Lanz-Englert B, Bickel H: Neuropsychological and biochemical investigations in heterozygotes for phenylketonuria during ingestion of high dose aspartame (a sweetener containing phenylalanine). Hum Genet 93:369–374, 1994.
Wolraich ML, Lindgren SD, Stumbo PJ, Stegink LD, Appelbaum MI, Kiritsy MC: Effects of diets high in sucrose or aspartame on the behavior and cognitive performance of children. N Engl J Med 330:301–307, 1994.
Shaywitz BA, Sullivan CM, Anderson GM, Gillespie SM, Sullivan B, Shaywitz SE: Aspartame, behavior, and cognitive function in children with attention deficit disorder [see comments]. Pediatrics 93:70–75, 1994. Comment in: Pediatrics 93:127–128, 1994. Comment in: Pediatrics 94:576, 1994.
Conners CK: The acute effects of caffeine on evoked response, vigilance, and activity level in hyperkinetic children. J Abnorm Child Psychol 7:145–151, 1979.
Nehlig A, Debry G: Consequences on the newborn of chronic maternal consumption of coffee during gestation and lactation: A review. J Am Coll Nutr 13:6–21, 1994.
Nehlig A, Debry G: Potential teratogenic and neurodevelopmental consequences of coffee and caffeine exposure: A review on human and animal data. Neurotoxicol Teratol 16:531–543, 1994.
American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders, ed 4. Washington, DC: American Psychiatric Association Press, 1994.
Greden JF, Fontaine P, Lubetsky M, et al: Anxiety and depression associated with caffeinism among psychiatric inpatients. Am J Psychiatry 134:963–966, 1978.
Gilliland K, Andress D: Ad lib caffeine consumption, symptoms of caffeinism and academic performance. Am J Psychiatry 138:512–514, 1981.
Boulenger JP, Uhde TW, Wolff EA, et al: Increased sensitivity to caffeine in patients with panic disorder. Arch Gen Psychiatry 41:1067–1071, 1984.
Eaton WW, McLeod J: Consumption of coffee or tea and symptoms of anxiety. Am J Public Health 74: 66–68, 1984.
Snyder SH: Adenosine as a mediator of the behavioral effects of xanthines, in Dews PB (ed): Caffeine. New York, Springer-Verlag, 1984.
Schnackenberg RC: Caffeine as a substitute for schedule II stimulants in hyperkinetic children. Am J Psychiatry 130:796–798, 1973.
Huestis RD, Arnold LE, Smeltzer DJ: Caffeine versus methylphenidate and d-amphetamine in minimal brain dysfunction: A double-blind comparison. Am J Psychiatry 132:868–870, 1975.
Levitón A: Behavioral correlates of caffeine consumption by children. Paper presented at the 60th Annual Meeting of the American Academy of Pediatrics, New Orleans, 1991. Clin Pediatr 31:742–750, 1992.
Rapoport JL, Berg CJ, Ismond DR, et al: Behavioral effects of caffeine in children:Relationship between dietary choice and effects of caffeine challenge. Arch Gen Psychiatry 41:1073–1079, 1984.
Wurtman RJ, Wurtman JJ (eds): Nutrition and the Brain. New York, Raven Press, 1979, vol 3.
Eisenberg J, Asnis GM, van Praag HM, et al: Effect of tyrosine on attention deficit disorder with hyperactivity. J Clin Psychiatry 49:193–195, 1988.
Colquhoun ID: Attention deficit/hyperactive disorder: A dietary/nutritional approach. Ther Care Educ 3: 159–172, 1994.
Goyer RA: Nutrition and metal toxicity. Am J Clin Nutr 61(Suppl.):646S-650S, 1995.
Wasserman GA, Graziano JH, Factor-Litvak P, Popovac D, Morina N, Musabegovic A, Vrenezi N, Capuni-Paracka S, Lekic V, Preteni-Redjepi E, et al: Consequences of lead exposure and iron supplementation on childhood development at age 4 years. Neurotoxicol Teratol 16:233–240, 1994.
Benton D, Roberts G: Effect of vitamin and mineral supplementation on intelligence of a sample of schoolchildren. Lancet 1:140–143, 1988.
Crombie IK, Todman J, McNeill G, et al: Effect of vitamin and mineral supplementation on verbal and nonverbal reasoning of schoolchildren. Lancet 335:744–747, 1990.
Nelson M, Naismith DJ, Burley V, et al: Nutrient intakes, vitamin/mineral supplementation and intelligence in British schoolchildren. Br J Nutr 64:13–22, 1990.
Benton D, Buts JP: Vitamin/mineral supplementation and intelligence. Lancet 335:1158–1160, 1990.
Schoenthaler S J, Amos SP, Eysenck HJ, et al: Controlled trial of vitamin-mineral supplementation: Effects on intelligence and performance. Pers Individ Differ 12:351–362, 1991.
Benton D, Cook R: Vitamin and mineral supplements improve the intelligence scores and concentration of six-year-old children. Pers Individ Differ 12:1151–1158, 1991.
Nelson M, Paul AA: Unpublished work, described in Committee on Medical Aspects of Food Policy, Dietary Sugars and Human Disease: Department of Health Report on Health and Social Subjects No. 37. London, HMSO.
Lipton MA, Mailman RB, Nemeroff CB: Vitamins, megavitamin therapy, and the nervous system, in Wurtman RJ, Wurtman JJ (eds): Nutrition and the Brain. New York, Raven Press, 1979, vol 3.
Aman MG, Singh NN: Vitamin, mineral and dietary treatments, in Aman MG, Singh NN (eds): Psychophar-macology of the Developmental Disabilities. New York, Springer-Verlag, 1988.
Haslam RH, Dalby JT, Rademaker AW: Effects of megavitamin therapy on children with attention deficit disorders. Pediatrics 74:103–111, 1984.
Arnold LE, Christopher J, Heustis RD, et al: Megavitamins for minimal brain dysfunction. JAMA 240:2642–2643, 1978.
Kershner J, Hawke W: Megavitamins and learning disorders: A controlled double-blind experiment. JNutr 109:819–826, 1979.
Cott A: Megavitamins: The orthomolecular approach to behavioral disorders and learning disabilities. Acad Ther 7:245–258, 1972.
Rimland B: An orthomolecular study of psychotic children. J. Orthomol Psychiatry 3:371–377, 1974.
Rimland B, Calloway E, Dreyfus P: The effect of high doses of vitamin B6 on autistic children: A double-blind crossover study. Am J Psychiatry 135:472–475, 1978.
Aman MG, VanBourgondien ME, Wolford PL, Sarphare G: Psychotropic and anticonvulsant drugs in subjects with autism: Prevalence and patterns of use. J Am Acad Child Adolesc Psychiatry 34:1672–1681, 1995.
Aman MG, Kern RA: The efficacy of folic acid in fragile X syndrome and other developmental disabilities. J Child Adolesc Psychopharmacol 1:285–295, 1990.
Kozlowski BW: Megavitamin treatment of mental retardation in children: A review of effects on behavior and cognition. J Child Adolesc Psychopharmacol 2:307–320, 1992.
Pollitt E, Leibel RL, Greenfield DB: Iron deficiency and cognitive test performance in preschool children. Nutr Behav 1:137–146, 1983.
Moser-Veillon PB: Zinc: Consumption patterns and dietary recommendations. J Am Diet Assoc 90:1089–1093, 1990.
Colquhoun I, Bunday S: A lack of essential fatty acids as a possible cause of hyperactivity in children. Med Hypotheses 7:673–679, 1981.
Arnold LG, Votolato NA, Kleykamp D, Baker GB, Bornstein RA: Does hair zinc predict amphetamine improvement of ADD/hyperactivity? Int J Neurosci 50:103–107, 1990.
Needleman HL: The neurobehavioral consequences of low lead exposure in childhood. Neurobehav Toxicol Teratol 4:729–732, 1982.
Needleman HL: Low-level lead exposure in the fetus and young child. Neurotoxicology 8:389–394, 1982.
Needleman HL: The persistent threat of lead: A singular opportunity. Am J Pub Health 79:643–645, 1989.
Needleman HL, Gunnoe C, Levitón A, Reed R, Peresie H, Matter C, Barrett P: Deficits in psychologic and classroom performance of children with elevated dentine lead levels. N Engl J Med 300:689–695, 1990.
Milar CR, Schroeder SR, Mushak P, et al: Failure to find hyperactivity in preschool children with moderately elevated lead burden. J Ped Psychol 1:85–95, 1981.
Thatcher RW, McAlaster R, Lester ML, et al: Comparisons among EEG, hair minerals and diet predictions of reading performance in children, in White S J, Teller V (eds): Annals of the New York Academy of Sciences. New York, New York Academy of Sciences, 1984 vol. 425 pp 421–423.
Lewis M, Worobey J, Ramsay DS, McCormack MK: Prenatal exposure to heavy metals: Effect on childhood cognitive skills and health status. Pediatrics 89:1010–1015, 1992.
Marlowe M: The violation of childhood: Toxic metals and developmental disabilities. J Orthomol Med 10:79–86, 1995.
Feingold B: Why Your Child Is Hyperactive. New York, Random House, 1975.
Harley JP, Ray RS, Tomasi L, et al: Hyperkinesis and food additives: Testing the Feingold hypothesis. Pediatrics 61:818–828, 1978.
Goldstein S, Ingersoll B: Controversial treatments for children with ADHD and impulse disorders, in Koziol LF, Stout CE, Ruben DH (eds): Handbook of Childhood Impulse Disorders and ADHD: Theory and Practice. Springfield, Ill, Charles C. Thomas, 1993, p. 236.
Kaplan BJ, McNicol J, Conte RA, et al: Dietary replacement in preschool-aged hyperactive boys. Pediatrics 83:7–17, 1989.
Egger J, Carter CM, Graham PJ, et al: Controlled trial of oligoantigenic treatment in the hyperkinetic syndrome. Lancet 1:540–545, 1985.
Boris M, Mandel FS: Foods and additives are common causes of the attention deficit hyperactive disorder in children. Ann Allergy 72:462–468, 1994.
Schwab EK, Conners CK: Nutrient-behavior research with children: Methods, considerations, and evaluation. J Am Diet Assoc 86(3):319–326, 1986.
Rowe KS, Rowe KJ: Synthetic food coloring and behavior: A dose response effect in a double-blind, placebo-controlled, repeated-measures study. J Pediatr 125:691–698, 1994.
Shrader WA: EPD History, Theory, and Results [on-line]. 1996. Available: http://www.tiac.net/users/kkv/epd-general.shtml
Egger J, Stolla A, McEwen LM: Controlled trial of hyposensitisation in children with food-induced hyperkinetic syndrome [see comments]. Lancet 339:1150–1153, 1992.
Krieger I: Pediatric Disorders of Feeding, Nutrition, and Metabolism. New York, John Wiley & Sons, 1982.
Editors and Affiliations
Rights and permissions
© 1999 Springer Science+Business Media New York
About this chapter
Cite this chapter
Conners, C.K., Sparrow, E.P. (1999). Nootropics And Foods. In: Werry, J.S., Aman, M.G. (eds) Practitioner’s Guide to Psychoactive Drugs for Children and Adolescents. Springer, Boston, MA. https://doi.org/10.1007/978-1-4899-0086-9_14
Publisher Name: Springer, Boston, MA
Print ISBN: 978-0-306-45885-9
Online ISBN: 978-1-4899-0086-9
eBook Packages: Springer Book Archive